Drug maker Bristol-Myers Squibb Co. said it has received a subpoena from the U.S. Securities and Exchange Commission as part of an investigation into bribery overseas.
Bristol-Myers said the subpoena received in March seeks information related to sales and marketing practices in “various countries.”
via Bristol-Myers Gets SEC Subpoena In Foreign Bribery Probe. — Dow Jones Newswires
